Plexera® Bioscience
Plexera® Bioscience manufactures high throughput Surface Plasmon Resonance (SPR) instruments providing the life sciences market with tools, content, and methods that simplify and accelerate required steps in the drug discovery and development process.
The study of proteomics presents researchers with costly analytical challenges due to the complexity and size of individual proteomes. When you consider the number of biologic interactions, the complexity grows exponentially. Researchers’ need for information has outpaced currently available technology. KX Array™ Technology developed by Plexera Bioscience addresses this complexity and the need for more information by combining label free, real-time detection methods with microarray based, high density assay formats. KX Array Technology utilizes Surface Plasmon Resonance, which provides a cost effective, high throughput solution for detecting and quantifying the binding and concentration of thousands of proteins in a single experiment.
Market applications target biomarker screening and discovery, biomolecular interactions of genomic materials and drug interactions. The bench scientist seeking new targets, pharmacologists seeking the pharmaco-dynamics of a drug or clinicians determining the efficacy of a drug, will all benefit from the information derived from the use of the Plexera platform.
Plexera® Bioscience manufactures high throughput Surface Plasmon Resonance (SPR) instruments providing the life sciences market with tools, content, and methods that simplify and accelerate required steps in the drug discovery and development process.
The study of proteomics presents researchers with costly analytical challenges due to the complexity and size of individual proteomes. When you consider the number of biologic interactions, the complexity grows exponentially. Researchers’ need for information has outpaced currently available technology. KX Array™ Technology developed by Plexera Bioscience addresses this complexity and the need for more information by combining label free, real-time detection methods with microarray based, high density assay formats. KX Array Technology utilizes Surface Plasmon Resonance, which provides a cost effective, high throughput solution for detecting and quantifying the binding and concentration of thousands of proteins in a single experiment.
Market applications target biomarker screening and discovery, biomolecular interactions of genomic materials and drug interactions. The bench scientist seeking new targets, pharmacologists seeking the pharmaco-dynamics of a drug or clinicians determining the efficacy of a drug, will all benefit from the information derived from the use of the Plexera platform.